871P Randomized phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) unable for cisplatin (CP)-based chemotherapy (CT): NIVOTAX TTCC study

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 35; p. S624
Main Authors	Iglesias Docampo, L., Baste Rotllan, N., Oliva Bernal, M., Carral Maseda, A., Pérez Segura, P., Medina Colmenero, A., Cirauqui Cirauqui, B., Arrazubi Arrula, V., Martinez Trufero, J., Gutierrez Calderon, V., Garcia Castano, A., Rubió-Casadevall, J., Basterretxea, L., Alvarez Cabellos, R., del Barco Morillo, E., Bruixola, G., Flor, M.J., Assaf Pastrana, J.D., Caballero Daroqui, J., Mesia Nin, R.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.09.2024
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2024.08.932